Lindquist & Vennum works with venture capital firms and their portfolio companies from the initial investment through exit. With longstanding practices in life sciences and health law, our firm is very familiar with the industries in which venture capital funds most often invest—medical devices, biotechnology, and healthcare. We have also worked with companies in other high-tech areas such as digital printing, circuit manufacturing, software production, telecommunications, and clean technology, and with companies in the retail, restaurant, financial, manufacturing, recycling, and other industries.
We’ll put our experience to constructive use on your behalf, moving quickly to close deals while helping you avoid obstacles and make the most of opportunities.
Lindquist & Vennum guides clients through legal issues at every stage of the venture capital life cycle, including:
- Fund formation
- Investigation and due diligence
- Negotiating and documenting venture investments
- Private and public offerings of debt and equity securities
- Designing and implementing executive compensation packages
- Evaluating a target company’s intellectual property portfolio
- Structuring initial and follow-on investments
- Developing and implementing exit strategies (sales, mergers, and initial public offerings)
We also advise clients on the full spectrum of business matters that venture capital firms and their portfolio companies often encounter, such as:
- Strategic relationships with suppliers, distributors, licensees, etc.
- Strategic alliances, joint ventures, business combinations, and sale transactions
- Initial public offerings
- Corporate governance
- Securities law issues
- Tax matters
Moreover, if issues in specific areas of business arise at any point in the process, we can draw on the knowledge and experience of the attorneys in our firm who focus their practices on:
In recent years, Lindquist & Vennum’s work in the venture capital arena has included representing:
A corporate venture client in connection with a Series B investment in a California medical device company.
A corporate venture client in connection with restructuring its investment in a digital printing company in the Northeast.
A California-based medical device company in a Series B financing round. Multiple venture investors were involved in the financing, which resulted in an aggregate investment of approximately $20 million.
A medical device company conducting Series B, C, and D rounds of venture financing. The company has since gone public.
A venture-financed food service company in connection with its $11 million Series A preferred financing round.
An online retail company in connection with a financing round involving both preferred stock and warrants.
A Minnesota-based software company in connection with a Series B venture financing round
A Minnesota-based technology company in conducting a Series A venture financing round.